Search

Author/Creator Grund, Birgit

11. LB2305. Long Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection: Findings from the Extended Follow-up of the START Trial. (15th December 2022)

Authors:
Babiker, Abdel G; Lundgren, Jens; Sharma, Shweta; Grund, Birgit; Phillips, Andrew; Kan, Virginia L; Matthews, Gail; Klingman, Karin L; Neaton, James D
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts. (15th May 2018)

Authors:
Wright, Edwina J.; Grund, Birgit; Robertson, Kevin R.; Cysique, Lucette; Brew, Bruce J.; Collins, Gary L.; Poehlman-Roediger, Mollie; Vjecha, Michael J.; Penalva de Oliveira, Augusto César; Standridge, Barbara; Carey, Cate; Avihingsanon, Anchalee; Florence, Eric; Lundgren, Jens D.; Arenas-Pinto, ...
Journal:
AIDS
Issue:
Volume 32:Number 8(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial. (12th March 2018)

Authors:
Arenas-Pinto, Alejandro; Grund, Birgit; Sharma, Shweta; Martinez, Esteban; Cummins, Nathan; Fox, Julie; Klingman, Karin L; Sedlacek, Dalibor; Collins, Simon; Flynn, Patricia M; Chasanov, William M; Kedem, Eynat; Katlama, Christine; Sierra-Madero, Juan; Afonso, Claudia; Brouwers, Pim; Cooper, David A
Journal:
Clinical infectious diseases
Issue:
Volume 67:Number 3(2018)
Page Start:
420
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial. Issue 10 (October 2022)

Authors:
Ginde, Adit A.; Paredes, Roger; Murray, Thomas A.; Engen, Nicole; Grandits, Greg; Vekstein, Andrew; Ivey, Noel; Mourad, Ahmad; Sandkovsky, Uriel; Gottlieb, Robert L.; Berhe, Mezgebe; Jain, Mamta K.; Marines-Price, Rubria; Agbor Agbor, Barbine Tchamba; Mateu, Lourdes; España-Cueto, Sergio; Lladós,...
Journal:
Lancet
Issue:
Volume 10:Issue 10(2022)
Page Start:
972
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial. Issue 4 (April 2018)

Authors:
Molina, Jean-Michel; Grund, Birgit; Gordin, Fred; Williams, Ian; Schechter, Mauro; Losso, Marcello; Law, Matthew; Ekong, Ernest; Mwelase, Noluthando; Skoutelis, Athanasios; Wiselka, Martin J; Vandekerckhove, Linos; Benfield, Thomas; Munroe, David; Lundgren, Jens D; Neaton, James D
Journal:
Lancet
Issue:
Volume 5:Issue 4(2018)
Page Start:
e172
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗